[ad_1]

The single-source strategy affords sponsors and CROs modernized, oncology-focused options to optimize affected person knowledge assortment and trial administration

PHILADELPHIA, May 25, 2022 /PRNewswire/ — Signant Health, the chief in proof technology for contemporary scientific trials, launched as we speak a brand new resolution bundle to handle particular challenges and evolving wants in oncology scientific analysis. Leveraging Signant’s expertise in practically 1,000 oncology trials, the corporate’s new providing – Oncology Complete – combines confirmed trial optimization applied sciences with devoted, in-house scientific experience to satisfy the total necessities of oncology research whereas simplifying trial administration.

The built-in package deal contains Signant’s SmartSignals eCOA, eConsent, and RTSM software program options, to ship a extra intuitive and predictable examine expertise for all stakeholders. At its core is a extremely versatile eCOA resolution, which totally meets the altering regulatory expectations for patient-reported outcomes measurement in most cancers trials, enabling at-home or at-site assessments in addition to built-in affected person engagement and video go to options to advertise a simplified affected person expertise.

For investigative websites, automated knowledge document creation and reconciliation options streamline workflows whereas selling protocol adherence equivalent to guaranteeing compliance with inclusion/exclusion standards. Finally, Oncology Complete permits environment friendly, single-contract procurement and accelerated examine launches to assist sponsors and scientific analysis organizations meet strategic operational objectives.   

“As a longtime chief in eClinical options and scientific experience for conventional and decentralized oncology analysis for greater than twenty years, Signant already supplied a complete array of options few different suppliers can match,” commented Sanjiv Waghmare, Signant’s chief product officer. “Now with Oncology Complete, we’re providing a full-featured oncology proof technology platform mixed with Signant’s knowledgeable service and assist, all below one contract. From patient-reported outcomes knowledge seize to knowledgeable consent, affected person engagement, video visits and drugs administration, our single-source strategy permits sponsors to conduct easy and sophisticated trials effectively and cost-effectively.”     

Signant’s Oncology Complete resolution, out there now, will be utilized to any oncology program from early-phase, native research to pivotal multinational trials.

About Signant Health

Signant Health is the proof technology firm. We are targeted on leveraging software program, deep therapeutic and scientific data, and operational experience to constantly seize, mixture, and reveal high quality proof for scientific research throughout conventional, digital, and hybrid trial fashions. For greater than 20 years, over 400 sponsors and CROs of all sizes – together with all Top 20 pharma – have trusted Signant options for distant and site-based eCOA, eConsent, RTSM, provide chain administration, and knowledge high quality analytics. Learn extra at www.signanthealth.com.

Logo – https://mma.prnewswire.com/media/1202052/Signant_Health_Logo.jpg

Contact: 
Heather Bilinski
media@signanthealth.com
+1 (610).400-4141

SOURCE Signant Health

[ad_2]

Source link

#Signant #Introduces #Oncology #Complete #Featuring #Comprehensive #Clinical #Technology #Optimizing #Modern #Oncology #Trials

By Seth A. Dunbar

Seth Dunbar leads clinical research study operations and quality & compliance. He is experienced working with teams to help drug sponsors better leverage eSource data. With 10+ years of experience Seth brings expertise developing eClinical services that integrate data and technology to help companies optimise study execution.

Leave a Reply

Your email address will not be published.